emphycorp.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://emphycorp.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Emphycorp Inc Creating the future of Non-Steroidal Nasal
Description We are driven to create safer Nasal Spray drugs that provide a better quality of life for EmphyCorp Inc is a Private NJ Biotech focused on Providing Safer Rx Nasal Spray Drugs with no known side effects for the treatment of major Respiratory Diseases and COVID-19, including Pulmonary Fibrosis, Cystic Fibrosis, COPD, Flu, COVID-19, and
Keywords N/A
Server Information
WebSite emphycorp faviconemphycorp.com
Host IP 74.112.255.194
Location United States
Related Websites
Site Rank
More to Explore
emphycorp.com Valuation
US$1,285,455
Last updated: 2023-05-08 00:17:28

emphycorp.com has Semrush global rank of 8,233,900. emphycorp.com has an estimated worth of US$ 1,285,455, based on its estimated Ads revenue. emphycorp.com receives approximately 148,322 unique visitors each day. Its web server is located in United States, with IP address 74.112.255.194. According to SiteAdvisor, emphycorp.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,285,455
Daily Ads Revenue US$1,187
Monthly Ads Revenue US$35,598
Yearly Ads Revenue US$427,167
Daily Unique Visitors 9,889
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
emphycorp.com. A 300 IP: 74.112.255.194
emphycorp.com. NS 86400 NS Record: ns2.huntergrafx.net.
emphycorp.com. NS 86400 NS Record: ns1.huntergrafx.net.
emphycorp.com. MX 300 MX Record: 0 emphycorp.com.
emphycorp.com. TXT 14400 TXT Record: v=spf1 +a +mx +ip4:74.112.255.184 +ip4:74.112.255.194 ~all
HtmlToTextCheckTime:2023-05-08 00:17:28
United States Canada Mexico China Middle East Japan Europe Sales Marketing About Us About Us Management and Advisors OUR MEDICAL STUDIES Our Drug Pipeline Our Drug Pipeline PULMONARY FIBROSIS TREATMENT® COVID-19 TREATMENT® COVID-19 LONG HAULERS TREATMENT® FLU TREATMENT® UNMET NEEDS BREATHING TREATMENT® NON-STEROIDAL COPD NASAL SPRAY® 70% LOWER STEROID COPD® NON-STEROIDAL ALZHEIMER’S NASAL SPRAY® CONCUSSIONS TREATMENT® DRUG FREE CANCER PRE-TREATMENT® SMOKING CESSATION ORAL SPRAY® Conditions We Can Treat HYPOXEMIA PULMONARY FIBROSIS COVID-19 COVID LONG HAULERS FLU ASTHMA COPD EMPHYSEMA SARCOIDOSIS CYSTIC FIBROSIS (CF) CHRONIC BRONCHITIS INTERSTITIAL LUNG DISEASE VIRAL and BACTERIAL Infections FDA Submissions REGULATION OF NITRIC OXIDE SODIUM PYRUVATE N115 FDA SUBMISSIONS Contact Us Investor Relations Partnerships News/Press/Blog Emphycorp News & Peer Reviewed Articles PRESS RELEASES Blog NEW PULMONARY FIBROSIS TREATMENT United States Canada Mexico China Middle East Japan Europe Sales
HTTP Headers
HTTP/1.1 303 See other
Date: Fri, 29 Oct 2021 00:43:52 GMT
Server: Apache
Set-Cookie: 3256d0151a3443412c2d8ed7c940534b=o6cq6oh36njsabi2gpkk63vju2; path=/; secure
Location: https://emphycorp.com/
Content-Type: text/html; charset=utf-8

HTTP/1.1 200 OK
Date: Fri, 29 Oct 2021 00:43:53 GMT
Server: Apache
P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM"
Cache-Control: no-cache
Pragma: no-cache
Set-Cookie: 3256d0151a3443412c2d8ed7c940534b=4aav98rdvq55vf8u81iu0nq9t5; path=/; secure
Content-Type: text/html; charset=utf-8
emphycorp.com Whois Information
Domain Name: EMPHYCORP.COM
Registry Domain ID: 96712309_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domain.com
Registrar URL: http://www.domain.com
Updated Date: 2021-01-04T15:56:18Z
Creation Date: 2003-04-11T13:42:38Z
Registry Expiry Date: 2027-04-11T13:42:38Z
Registrar: Domain.com, LLC
Registrar IANA ID: 886
Registrar Abuse Contact Email: compliance@domain-inc.net
Registrar Abuse Contact Phone: 602-226-2389
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1.HUNTERGRAFX.NET
Name Server: NS2.HUNTERGRAFX.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T15:33:39Z <<<